Influence of the COVId-19 Pandemic on STRESS, and Screening Procedures (COVISTRESS Screening)

COVID-19 Screening Clinical Trial

Official title:

Influence of the COVId-19 Pandemic on STRESS, and Screening Procedures

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04538586
• Other study ID #: 2020 COVISTRESS Screening
• Status: Recruiting
• Start date: May 1, 2020
• Est. completion date: December 1, 2025

Study information

• Verified date: September 2020
• Source: University Hospital, Clermont-Ferrand
• Contact: Lise LACLAUTRE
• Phone: 0473754963
• Email: promo_interne_drci[@]chu-clermontferrand.fr
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Coronavirus has caused containment of more than a third of the world's population. Some countries have used a major screening strategy. Screening procedures, such as waiting (or resulting) for the test, can be stressful and can attract the most stressed people. However, there is currently no data on the relationship between stress and screening for SARS-CoV2

Description:

This is an observational study by REDCap questionnaire® via a flyer deposited in the waiting room of the COVID screening centres. No incentive to complete the questionnaire will be made. The self-survey will assess stress and its relationship to SARS-CoV2 screening procedures, socio-demographic factors or lifestyle habits. This Screening questionnaire includes 31 questions.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 1000
• Est. completion date: December 1, 2025
• Est. primary completion date: December 1, 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 16 Years and older

Eligibility

Inclusion Criteria:

• All volunteers who are screened

Exclusion Criteria:

• None

Related Conditions & MeSH terms

• COVID-19 Screening

Locations

Country	Name	City	State
France	Univeristy Hospital, Clermont-Ferrand	Clermont-Ferrand

Sponsors (2)

Lead Sponsor	Collaborator
University Hospital, Clermont-Ferrand	Faculty of Medicine and Paramedical Professions, Clermont-Ferrand, France

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Stress measures	Attitudes and stress related to screening procedure will be measured via questionnaire	Day 1
Secondary	Screening	Attitudes towards screening will be measured via questionnaire	Day 1
Secondary	Sociodemographic characteristics	Age, gender, qualification, personal work status, ethnicity, life characteristics and stress will be assessed by questionnaires	Day 1